Research Analysts’ Recent Ratings Updates for Transcat (TRNS)

Several analysts have recently updated their ratings and price targets for Transcat (NASDAQ: TRNS):

• 11/5/2026 – Transcat was upgraded by Zacks Research from “hold” to “strong-buy”.
• 11/4/2026 – Transcat was upgraded by Oppenheimer from “market perform” to “outperform”. They now have a $115.00 price target on the stock.
• 10/27/2026 – Transcat is now covered by CJS Securities. They set an “outperform” rating and a $115.00 price target on the stock.
• 10/21/2026 – Transcat was upgraded by Northland Securities from “market perform” to “outperform”. They now have a $95.00 price target on the stock.

Transcat Stock Performance

Shares of NASDAQ:TRNS opened at $108.64 on Monday. The company’s 50 day moving average price is $86.94 and its two-hundred day moving average price is $82.43. Transcat, Inc. has a 12-month low of $50.23 and a 12-month high of $110.47. The firm has a market cap of $1.02 billion, a PE ratio of 226.34 and a beta of 0.61. The company has a quick ratio of 2.19, a current ratio of 2.57 and a debt-to-equity ratio of 0.38.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.45 by $0.19. The company had revenue of $97.09 million for the quarter, compared to analysts’ expectations of $92.46 million. Transcat had a net margin of 1.26% and a return on equity of 6.14%. Equities research analysts predict that Transcat, Inc. will post 2.06 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Jaime A. Irick acquired 2,275 shares of the company’s stock in a transaction on Thursday, November 5th. The stock was purchased at an average cost of $101.26 per share, with a total value of $230,366.50. Following the acquisition, the chief executive officer directly owned 2,275 shares of the company’s stock, valued at approximately $230,366.50. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is currently owned by company insiders.

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.